Quantcast

Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

May 21, 2014

LONDON, May 21, 2014 /PRNewswire/ — Reportbuyer.com has added a new market research report:

Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.reportbuyer.com/pharma_healthcare/diagnostics/endocrine_testing_market_e2_fsh_hcg_lh_dheas_progesterone_testosterone_tsh_prolactin_cortisol_insulin_tests_others_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html

Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices.

On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the endocrine testing market and future opportunities are provided in the report. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Several other analytical perspectives such as Porter’s Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making.

The global endocrine testing market is segmented into the following categories:

Hernia Endocrine Testing Market, by Tests
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others (Gastrin, Thymosin, Secretin, etc.)

Endocrine Testing Market, by Diagnostic Technologies


Tandem Mass spectrometry
Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies
Monoclonal and Polyclonal Antibody Technologies
Sensor (Electrochemical, Biosensors, etc.) Technologies
Clinical Chemistry Technologies
Others (Liquid Chromatography + Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.)

Endocrine Testing Market, by Geography

Hospitals
Commercial Laboratories
Ambulatory Care Centers
Home Based Tests
Physician Offices

Endocrine Testing Market, by Geography

North America
Europe
Asia-Pacific
Rest of the World (RoW)

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.1.3 Models
1.3.1.4 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
2.2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
2.3 Global Endocrine Testing Market, by Diagnostic Technologies, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.1.1 Introduction to Elements of Endocrine System
3.1.2 Market Potential of Endocrine Testing Market
3.1.3 Future Scenario of Endocrine Testing Market
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
3.2.1.2 Consistent rise in geriatric population Worldwide
3.2.1.3 Technological advancements
3.2.2 Market Restraints
3.2.2.1 High cost of technology
3.2.2.2 Lack of healthcare awareness in emerging economies
3.2.3 Market Opportunity
3.2.3.1 Investment opportunity
3.3 Porter’s Five Force Analysis for the Global Endocrine Testing Market
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of substitutes
3.3.4 Threat of new entrants
3.3.5 Competitive rivalry
3.1 Market Attractiveness Analysis: Global Endocrine Technologies Market, by Geography

Chapter 4 Endocrine Testing Market, by Test
4.1 Overview
4.1.1 Global Endocrine Testing Market, by Test, 2011 – 2019 (USD Million)
4.2 Estradiol (E2) Test
4.2.1 Global Estradiol (E2) Test Market, 2011 – 2019 (USD Million)
4.3 Follicle Stimulating Hormone (FSH) Test
4.3.1 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 – 2019 (USD Million)
4.4 Human Chorionic Gonadotropin (hCG) Test
4.4.1 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 – 2019 (USD Million)
4.5 Luteinizing Hormone (LH) Test
4.5.1 Global Luteinizing Hormone (LH) Test Market, 2011 – 2019 (USD Million)
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Test
4.6.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 – 2019 (USD Million)
4.7 Progesterone Test
4.7.1 Global Progesterone Test Market, 2011 – 2019 (USD Million)
4.8 Testosterone Test
4.8.1 Global Testosterone Test Market, 2011 – 2019 (USD Million)
4.9 Thyroid Stimulating Hormone (TSH) Test
4.9.1 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 – 2019 (USD Million)
4.10 Prolactin Test
4.10.1 Global Prolactin Test Market, 2011 – 2019 (USD Million)
4.11 Cortisol Test
4.11.1 Global Cortisol Test Market, 2011 – 2019 (USD Million)
4.12 Insulin Test
4.12.1 Global Insulin Test Market, 2011 – 2019 (USD Million)
4.13 Others
4.13.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 5 Endocrine Testing Market, by Diagnostic Technologies
5.1 Overview
5.1.1 Global Endocrine Testing Market, by Diagnostic Technologies 2011 – 2019 (USD Million)
5.2 Tandem Mass Spectrometry
5.2.1 Global Tandem Mass Spectrometry Market, 2011 – 2019 (USD Million)
5.3 Immunoassay (Enzyme Linked Assays(EIA), Radio Immunoassay (RIA))Technologies
5.3.1 Global Immunoassay Technologies Market, 2011 – 2019 (USD Million)
5.4 Monoclonal and Polyclonal Antibody Technologies
5.4.1 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 – 2019 (USD Million)
5.5 Sensor Technologies
5.5.1 Global Sensor Technologies Market, 2011 – 2019 (USD Million)
5.6 Clinical Chemistry Technologies
5.6.1 Global Clinical Chemistry Technologies Market, 2011 – 2019 (USD Million)
5.7 Others ((Liquid Chromatography + Tandem Mass Spectrometry (LC-MS/MS), High performance Liquid Chromatography (HPLC), etc.)
5.7.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 6 Endocrine Testing Market, by End Users
6.1 Overview
6.1.1 Global Endocrine Testing Market, by End Users 2011 – 2019 (USD Million)
6.2 Hospitals
6.2.1 Global Hospitals Market, 2011 – 2019 (USD Million)
6.3 Commercial Laboratories
6.3.1 Global Commercial Laboratories Market, 2011 – 2019 (USD Million)
6.4 Ambulatory Care Centers
6.4.1 Global Ambulatory Care Centers Market, 2011 – 2019 (USD Million)
6.5 Home Based Tests
6.5.1 Global Home Based Tests Market, 2011 – 2019 (USD Million)
6.6 Physician Offices
6.6.1 Global Physician Offices Market, 2011 – 2019 (USD Million)

Chapter 7 Endocrine Testing Market, by Geography
7.1 Overview
7.1.1 Global Endocrine Testing Market, by Geography 2011 – 2019 (USD Million)
7.2 North America
7.2.1 North America Endocrine Testing Market, 2011 – 2019 (USD Million)
7.3 Europe
7.3.1 Europe Endocrine Testing Market, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
7.4.1 Asia-Pacific Endocrine Testing Market, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
7.5.1 RoW Endocrine Testing Market, 2011 – 2019 (USD Million)

Chapter 8 Competitive Landscape
8.1 Market Share by Key Players: Global Endocrine Testing Market, 2012 (%)
8.1.1 Global Endocrine Testing Market Share Analysis, by Key Players, 2012 (%)

Chapter 9 Recommendations
9.1 Market strategies for success
9.2 Barriers to be considered

Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Developments
10.2 AB SCIEX LLC
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.2.5 Recent Developments
10.3 Agilent Technologies
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Developments
10.4 Biomedical Diagnostics
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Developments
10.5 bioMerieux
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Developments
10.6 Bio-Rad Laboratories, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.6.5 Recent Developments
10.7 DiaSorin S.p.A
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.7.5 Recent Developments
10.8 F. Hoffmann-La Roche Ltd.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.8.5 Recent Developments
10.9 Laboratory Corporation of America Holdings (LabCorp)
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.9.5 Recent Developments
10.10 Ortho Clinical Diagnostics
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.10.5 Recent Developments
10.11 Quest Diagnostics
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.11.5 Recent Developments
10.12 Siemens Healthcare
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.12.5 Recent Developments
10.13 Sysmex Corporation
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.13.5 Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.14.5 Recent Developments

List of Figures

FIG. 1 Endocrine Testing: Market Segmentation
FIG. 2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
FIG. 3 Global Endocrine Testing Market, by Diagnostic Technology, 2012 (USD Million)
FIG. 4 Introduction to Endocrine Glands/organs
FIG. 5 Global Rate of Aging Population
FIG. 6 Porter’s Five Forces Analysis: Global Endocrine Testing Market
FIG. 7 Market Attractiveness Analysis: Global Endocrine Testing Market, by Geography
FIG. 8 Global Estradiol (E2) Test Market, 2011 – 2019 (USD Million)
FIG. 9 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 – 2019 (USD Million)
FIG. 10 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 – 2019 (USD Million)
FIG. 11 Global Luteinizing Hormone (LH) Test Market, 2011 – 2019 (USD Million)
FIG. 12 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 – 2019 (USD Million)
FIG. 13 Global Progesterone Test Market, 2011 – 2019 (USD Million)
FIG. 14 Global Testosterone Test Market, 2011 – 2019 (USD Million)
FIG. 15 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 – 2019 (USD Million)
FIG. 16 Global Prolactin Test Market, 2011 – 2019 (USD Million)
FIG. 17 Global Cortisol Test Market, 2011 – 2019 (USD Million)
FIG. 18 Global Insulin Test Market, 2011 – 2019 (USD Million)
FIG. 19 Global Others Market, 2011 – 2019 (USD Million)
FIG. 20 Global Tandem Mass Spectrometry Market, 2011 – 2019 (USD Million)
FIG. 21 Global Immunoassay Technologies Market, 2011 – 2019 (USD Million)
FIG. 22 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 – 2019 (USD Million)
FIG. 23 Global Sensor Technologies Market, 2011 – 2019 (USD Million)
FIG. 24 Global Clinical Chemistry Technologies Market, 2011 – 2019 (USD Million)
FIG. 25 Global Others Market, 2011 – 2019 (USD Million)
FIG. 26 Global Hospitals Market, 2011 – 2019 (USD Million)
FIG. 27 Global Commercial Laboratories Market, 2011 – 2019 (USD Million)
FIG. 28 Global Ambulatory Care Centers Market, 2011 – 2019 (USD Million)
FIG. 29 Global Home Based Tests Market, 2011 – 2019 (USD Million)
FIG. 30 Global Physician Offices Market, 2011 – 2019 (USD Million)
FIG. 31 North America Endocrine Testing Market, 2011 – 2019 (USD Million)
FIG. 32 Europe Endocrine Testing Market, 2011 – 2019 (USD Million)
FIG. 33 Asia-Pacific Endocrine Testing Market, 2011 – 2019 (USD Million)
FIG. 34 RoW Endocrine Testing Market, 2011 – 2019 (USD Million)
FIG. 35 Endocrine Testing: Market Share, by Key Players, 2012 (%)
FIG. 36 Abbott Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 37 Agilent Technologies, Annual Revenue: 2010 – 2012 (USD million,)
FIG. 38 bioMerieux, Annual Sales Revenue: 2010 – 2012 (USD Million) Conversion Rate 1Euro = 1.34 USD
FIG. 39 Bio-Rad, Annual Sales Revenue : 2010 – 2012 (USD Million)
FIG. 40 DiaSorin, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 41 F. Hoffmann-La Roche Ltd.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 42 LabCorp: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 43 Ortho Clinical Diagnostics, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 44 Quest Diagnostics, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 45 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 46 Sysmex Corporation, Annual Sales: 2011 – 2013 (USD million)
FIG. 47 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Endocrine Testing Market, by Test, 2011 – 2019 (USD Million)
TABLE 6 Estradiol Test Result Range
TABLE 7 The Reasons For Performing FSH Test
TABLE 8 Progesterone Test Result Range
TABLE 9 Global Endocrine Testing Market, by Diagnostic Technologies 2011 – 2019 (USD Million)
TABLE 10 Global Endocrine Testing Market, by Ed Users 2011 – 2019 (USD Million)
TABLE 11 Global Endocrine Testing Market, by Geography 2011 – 2019 (USD Million)


Read the full report:
Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.reportbuyer.com/pharma_healthcare/diagnostics/endocrine_testing_market_e2_fsh_hcg_lh_dheas_progesterone_testosterone_tsh_prolactin_cortisol_insulin_tests_others_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus